Research library

1,776 reports · By date added

Goldman Sachs: Gan & Lee Pharmaceuticals' third-quarter results miss expectations: Overseas licensing revenue delayed, while innovative drug progress supports growth outlook

Third-quarter revenue rose 16.9% year on year, but Goldman Sachs said a delay in recognizing business development and licensing revenue weighed on results. Overseas sales and two innovative drug candidates made progress, while potentially higher R&D spending prompted Goldman Sachs to lower its earnings forecasts for the next two years.

HSBC: Visiting Shanghai and Hangzhou property markets: supply determines the pace of sales, while completed-home sales reform has limited near-term impact

The residential markets in Shanghai and Hangzhou have improved since HSBC’s first-quarter visit, but new-home sales have slowed from their spring peak. High-quality, differentiated projects continue to sell relatively quickly, while concentrated supply has slowed sales of luxury homes; Greentown says the reform had a smaller-than-expected impact on sales from September to October.